These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 28273731

  • 1. Ovarian morphology in polycystic ovary syndrome: estimates from 2D and 3D ultrasound and magnetic resonance imaging and their correlation to anti-Müllerian hormone.
    Nylander M, Frøssing S, Bjerre AH, Chabanova E, Clausen HV, Faber J, Skouby SO.
    Acta Radiol; 2017 Aug; 58(8):997-1004. PubMed ID: 28273731
    [Abstract] [Full Text] [Related]

  • 2. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP, Bentzen JG, Pinborg A, Loft A, Forman JL, Thuesen LL, Cohen A, Hougaard DM, Nyboe Andersen A.
    Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
    [Abstract] [Full Text] [Related]

  • 3. Ovarian volume and antral follicle count assessed by MRI and transvaginal ultrasonography: a methodological study.
    Leonhardt H, Gull B, Stener-Victorin E, Hellström M.
    Acta Radiol; 2014 Mar; 55(2):248-56. PubMed ID: 23926234
    [Abstract] [Full Text] [Related]

  • 4. Ovarian morphology assessed by magnetic resonance imaging in women with and without polycystic ovary syndrome and associations with antimüllerian hormone, free testosterone, and glucose disposal rate.
    Leonhardt H, Hellström M, Gull B, Lind AK, Nilsson L, Janson PO, Stener-Victorin E.
    Fertil Steril; 2014 Jun; 101(6):1747-56.e1-3. PubMed ID: 24661732
    [Abstract] [Full Text] [Related]

  • 5. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S, Laven JSE, Duhamel A, Dewailly D.
    Hum Reprod; 2017 Aug 01; 32(8):1723-1731. PubMed ID: 28854584
    [Abstract] [Full Text] [Related]

  • 6. Each small antral follicle in ovaries of women with polycystic ovary syndrome produces more antimüllerian hormone than its counterpart in a normal ovary: an observational cross-sectional study.
    Bhide P, Dilgil M, Gudi A, Shah A, Akwaa C, Homburg R.
    Fertil Steril; 2015 Feb 01; 103(2):537-41. PubMed ID: 25467043
    [Abstract] [Full Text] [Related]

  • 7. Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women.
    Wongwananuruk T, Panichyawat N, Indhavivadhana S, Rattanachaiyanont M, Angsuwathana S, Techatraisak K, Pratumvinit B, Sa-Nga-Areekul N.
    Taiwan J Obstet Gynecol; 2018 Aug 01; 57(4):499-506. PubMed ID: 30122568
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of three-dimensional SonoAVC ultrasound for antral follicle count in infertile women: its agreement with conventional two-dimensional ultrasound and serum levels of anti-Müllerian hormone.
    Peres Fagundes PA, Chapon R, Olsen PR, Schuster AK, Mattia MMC, Cunha-Filho JS.
    Reprod Biol Endocrinol; 2017 Dec 16; 15(1):96. PubMed ID: 29246176
    [Abstract] [Full Text] [Related]

  • 9. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
    Alebić MŠ, Stojanović N, Duhamel A, Dewailly D.
    Hum Reprod; 2015 Aug 16; 30(8):1927-33. PubMed ID: 26048913
    [Abstract] [Full Text] [Related]

  • 10. Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society.
    Dewailly D, Lujan ME, Carmina E, Cedars MI, Laven J, Norman RJ, Escobar-Morreale HF.
    Hum Reprod Update; 2014 Aug 16; 20(3):334-52. PubMed ID: 24345633
    [Abstract] [Full Text] [Related]

  • 11. [CORRELATION OF ANTI-MULLERIAN HORMONE WITH HORMONAL AND OVARIAN MORPHOLOGICAL CHARACTERISTICS IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME WITH AND WITHOUT INSULIN RESISTANCE].
    Asanidze E, Khristesashvili J, Pkhaladze L, Barbakadze L.
    Georgian Med News; 2018 Feb 16; (Issue):34-40. PubMed ID: 29578420
    [Abstract] [Full Text] [Related]

  • 12. Phenotypic variation in anti-Mullerian hormone (AMH) production per follicle in women with polycystic ovary syndrome (PCOS) and isolated polycystic ovarian morphology (PCOM): an observational cross-sectional study.
    Bhide P, Kulkarni A, Dilgil M, Dhir P, Shah A, Gudi A, Homburg R.
    Gynecol Endocrinol; 2017 Oct 16; 33(10):801-806. PubMed ID: 28454499
    [Abstract] [Full Text] [Related]

  • 13. Validation of an Anti-Müllerian Hormone Cutoff for Polycystic Ovarian Morphology in the Diagnosis of Polycystic Ovary Syndrome in the HARMONIA Study: Protocol for a Prospective, Noninterventional Study.
    Piltonen TT, Allegranza D, Hund M, Buck K, Sillman J, Arffman RK.
    JMIR Res Protoc; 2024 Feb 06; 13():e48854. PubMed ID: 38319689
    [Abstract] [Full Text] [Related]

  • 14. The relationship between serum anti-Müllerian hormone levels and the follicular arrest for women with polycystic ovary syndrome.
    Li J, Li R, Yu H, Zhao S, Yu Y, Qiao J.
    Syst Biol Reprod Med; 2015 Apr 06; 61(2):103-9. PubMed ID: 25329139
    [Abstract] [Full Text] [Related]

  • 15. Serum anti-Müllerian hormone and ovarian morphology assessed by magnetic resonance imaging in response to acupuncture and exercise in women with polycystic ovary syndrome: secondary analyses of a randomized controlled trial.
    Leonhardt H, Hellström M, Gull B, Lind AK, Nilsson L, Janson PO, Stener-Victorin E.
    Acta Obstet Gynecol Scand; 2015 Mar 06; 94(3):279-87. PubMed ID: 25545309
    [Abstract] [Full Text] [Related]

  • 16. Serum anti-Müllerian hormone concentration in women with polycystic ovary syndrome and type 1 diabetes mellitus.
    Łebkowska A, Adamska A, Karczewska-Kupczewska M, Nikołajuk A, Otziomek E, Milewski R, Górska M, Wołczyński S, Kowalska I.
    Metabolism; 2016 May 06; 65(5):804-811. PubMed ID: 26961579
    [Abstract] [Full Text] [Related]

  • 17. Anti-Müllerian hormone as a diagnostic tool for PCOS under different diagnostic criteria in an unselected population.
    Bozdag G, Mumusoglu S, Coskun ZY, Yarali H, Yildiz BO.
    Reprod Biomed Online; 2019 Sep 06; 39(3):522-529. PubMed ID: 31182353
    [Abstract] [Full Text] [Related]

  • 18. Relationship between 17-hydroxyprogesterone responses to human chorionic gonadotropin and markers of ovarian follicle morphology in women with polycystic ovary syndrome.
    Maas KH, Chuan SS, Cook-Andersen H, Su HI, Duleba A, Chang RJ.
    J Clin Endocrinol Metab; 2015 Jan 06; 100(1):293-300. PubMed ID: 25313914
    [Abstract] [Full Text] [Related]

  • 19. Serum anti-Mullerian hormone assessment of ovarian reserve and polycystic ovary syndrome status over the reproductive lifespan.
    Tremellen K, Zander-Fox D.
    Aust N Z J Obstet Gynaecol; 2015 Aug 06; 55(4):384-9. PubMed ID: 26230428
    [Abstract] [Full Text] [Related]

  • 20. Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?
    Eilertsen TB, Vanky E, Carlsen SM.
    Hum Reprod; 2012 Aug 06; 27(8):2494-502. PubMed ID: 22693172
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.